AAPL345.28-3.63 (-1.04%) ▼|ABBV296.50+5.71 (+1.96%) ▲|ABT106.24+1.67 (+1.60%) ▲|ACN252.82+5.60 (+2.27%) ▲|ADBE254.32+6.20 (+2.50%) ▲|AMAT398.75-22.92 (-5.43%) ▼|AMD512.09-54.33 (-9.59%) ▼|AMGN470.64+9.91 (+2.15%) ▲|AMT187.51+1.63 (+0.88%) ▲|AMZN236.35-7.44 (-3.05%) ▼|AVGO328.06-16.94 (-4.91%) ▼|AXP319.58-4.13 (-1.28%) ▼|BA172.97+0.32 (+0.19%) ▲|BAC50.21-0.94 (-1.83%) ▼|BKNG148.89-1.55 (-1.03%) ▼|BLK1,154.76-21.49 (-1.83%) ▼|BMY62.86+1.47 (+2.39%) ▲|BNY147.39-1.98 (-1.33%) ▼|BRK-B545.63+3.67 (+0.68%) ▲|C121.93-3.83 (-3.05%) ▼|CAT634.18-13.21 (-2.04%) ▼|CL95.49+2.33 (+2.50%) ▲|CMCSA22.96+0.69 (+3.08%) ▲|COF204.92-3.82 (-1.83%) ▼|COP152.18+2.15 (+1.43%) ▲|COST1,011.58+16.97 (+1.71%) ▲|CRM230.96+0.06 (+0.02%) ▲|CSCO104.10-4.50 (-4.14%) ▼|CVS90.60+0.27 (+0.30%) ▲|CVX235.88+4.42 (+1.91%) ▲|DE671.37+11.37 (+1.72%) ▲|DHR233.94-3.04 (-1.28%) ▼|DIS111.54+0.63 (+0.56%) ▲|DUK127.48+1.58 (+1.26%) ▲|EMR167.35-3.39 (-1.99%) ▼|FDX316.55+8.73 (+2.84%) ▲|GD376.54+5.72 (+1.54%) ▲|GE305.51-7.55 (-2.41%) ▼|GEV865.54-22.31 (-2.51%) ▼|GILD171.89+6.28 (+3.79%) ▲|GM85.91+0.19 (+0.22%) ▲|GOOG278.53-3.79 (-1.34%) ▼|GOOGL279.67-4.15 (-1.46%) ▼|GS895.67-32.07 (-3.46%) ▼|HD328.79-0.19 (-0.06%) ▼|HON219.91-2.23 (-1.00%) ▼|IBM256.38-1.90 (-0.74%) ▼|INTC66.03-26.05 (-28.29%) ▼|INTU340.69+9.50 (+2.87%) ▲|ISRG444.16-4.60 (-1.03%) ▼|JNJ277.09+1.89 (+0.69%) ▲|JPM337.20-6.38 (-1.86%) ▼|KO94.47+1.65 (+1.78%) ▲|LIN513.79+10.64 (+2.11%) ▲|LLY1,427.41+53.71 (+3.91%) ▲|LMT642.47-1.12 (-0.17%) ▼|LOW208.43+1.15 (+0.55%) ▲|LRCX242.06-12.33 (-4.85%) ▼|MA633.48-2.22 (-0.35%) ▼|MCD258.83+1.45 (+0.56%) ▲|MDLZ64.59+2.06 (+3.29%) ▲|MDT97.24+0.13 (+0.13%) ▲|META618.49-6.03 (-0.97%) ▼|MMM176.45-0.91 (-0.51%) ▼|MO77.95+1.20 (+1.56%) ▲|MRK148.90+2.57 (+1.76%) ▲|MS184.46-4.40 (-2.33%) ▼|MSFT521.48-8.67 (-1.63%) ▼|MU892.51-41.76 (-4.47%) ▼|NEE83.43+1.29 (+1.57%) ▲|NFLX62.53+0.48 (+0.77%) ▲|NKE38.89+0.47 (+1.21%) ▲|NOW107.09-2.59 (-2.36%) ▼|NVDA206.79-6.87 (-3.22%) ▼|ORCL133.51-6.05 (-4.34%) ▼|PEP136.21+2.42 (+1.81%) ▲|PFE30.32+0.37 (+1.22%) ▲|PG163.24+2.65 (+1.65%) ▲|PLTR187.24-9.18 (-4.67%) ▼|PM210.36+1.86 (+0.89%) ▲|QCOM167.72-17.69 (-9.54%) ▼|RTX200.05+0.65 (+0.33%) ▲|SBUX103.34-2.17 (-2.06%) ▼|SCHW88.66-0.82 (-0.91%) ▼|SO94.04+1.05 (+1.12%) ▲|SPG216.89+1.17 (+0.54%) ▲|T21.46+0.54 (+2.56%) ▲|TMO703.64-5.54 (-0.78%) ▼|TMUS155.31+8.02 (+5.45%) ▲|TSLA396.93-6.37 (-1.58%) ▼|TXN302.07-9.35 (-3.00%) ▼|UBER65.09-0.65 (-0.99%) ▼|UNH408.45-2.46 (-0.60%) ▼|UNP302.17+0.24 (+0.08%) ▲|UPS108.29+0.96 (+0.90%) ▲|USB59.98-0.66 (-1.09%) ▼|V413.10+2.56 (+0.62%) ▲|VZ44.83+1.17 (+2.67%) ▲|WFC83.93-0.89 (-1.04%) ▼|WMT123.13+1.88 (+1.55%) ▲|XOM187.59+4.30 (+2.35%) ▲|AAPL345.28-3.63 (-1.04%) ▼|ABBV296.50+5.71 (+1.96%) ▲|ABT106.24+1.67 (+1.60%) ▲|ACN252.82+5.60 (+2.27%) ▲|ADBE254.32+6.20 (+2.50%) ▲|AMAT398.75-22.92 (-5.43%) ▼|AMD512.09-54.33 (-9.59%) ▼|AMGN470.64+9.91 (+2.15%) ▲|AMT187.51+1.63 (+0.88%) ▲|AMZN236.35-7.44 (-3.05%) ▼|AVGO328.06-16.94 (-4.91%) ▼|AXP319.58-4.13 (-1.28%) ▼|BA172.97+0.32 (+0.19%) ▲|BAC50.21-0.94 (-1.83%) ▼|BKNG148.89-1.55 (-1.03%) ▼|BLK1,154.76-21.49 (-1.83%) ▼|BMY62.86+1.47 (+2.39%) ▲|BNY147.39-1.98 (-1.33%) ▼|BRK-B545.63+3.67 (+0.68%) ▲|C121.93-3.83 (-3.05%) ▼|CAT634.18-13.21 (-2.04%) ▼|CL95.49+2.33 (+2.50%) ▲|CMCSA22.96+0.69 (+3.08%) ▲|COF204.92-3.82 (-1.83%) ▼|COP152.18+2.15 (+1.43%) ▲|COST1,011.58+16.97 (+1.71%) ▲|CRM230.96+0.06 (+0.02%) ▲|CSCO104.10-4.50 (-4.14%) ▼|CVS90.60+0.27 (+0.30%) ▲|CVX235.88+4.42 (+1.91%) ▲|DE671.37+11.37 (+1.72%) ▲|DHR233.94-3.04 (-1.28%) ▼|DIS111.54+0.63 (+0.56%) ▲|DUK127.48+1.58 (+1.26%) ▲|EMR167.35-3.39 (-1.99%) ▼|FDX316.55+8.73 (+2.84%) ▲|GD376.54+5.72 (+1.54%) ▲|GE305.51-7.55 (-2.41%) ▼|GEV865.54-22.31 (-2.51%) ▼|GILD171.89+6.28 (+3.79%) ▲|GM85.91+0.19 (+0.22%) ▲|GOOG278.53-3.79 (-1.34%) ▼|GOOGL279.67-4.15 (-1.46%) ▼|GS895.67-32.07 (-3.46%) ▼|HD328.79-0.19 (-0.06%) ▼|HON219.91-2.23 (-1.00%) ▼|IBM256.38-1.90 (-0.74%) ▼|INTC66.03-26.05 (-28.29%) ▼|INTU340.69+9.50 (+2.87%) ▲|ISRG444.16-4.60 (-1.03%) ▼|JNJ277.09+1.89 (+0.69%) ▲|JPM337.20-6.38 (-1.86%) ▼|KO94.47+1.65 (+1.78%) ▲|LIN513.79+10.64 (+2.11%) ▲|LLY1,427.41+53.71 (+3.91%) ▲|LMT642.47-1.12 (-0.17%) ▼|LOW208.43+1.15 (+0.55%) ▲|LRCX242.06-12.33 (-4.85%) ▼|MA633.48-2.22 (-0.35%) ▼|MCD258.83+1.45 (+0.56%) ▲|MDLZ64.59+2.06 (+3.29%) ▲|MDT97.24+0.13 (+0.13%) ▲|META618.49-6.03 (-0.97%) ▼|MMM176.45-0.91 (-0.51%) ▼|MO77.95+1.20 (+1.56%) ▲|MRK148.90+2.57 (+1.76%) ▲|MS184.46-4.40 (-2.33%) ▼|MSFT521.48-8.67 (-1.63%) ▼|MU892.51-41.76 (-4.47%) ▼|NEE83.43+1.29 (+1.57%) ▲|NFLX62.53+0.48 (+0.77%) ▲|NKE38.89+0.47 (+1.21%) ▲|NOW107.09-2.59 (-2.36%) ▼|NVDA206.79-6.87 (-3.22%) ▼|ORCL133.51-6.05 (-4.34%) ▼|PEP136.21+2.42 (+1.81%) ▲|PFE30.32+0.37 (+1.22%) ▲|PG163.24+2.65 (+1.65%) ▲|PLTR187.24-9.18 (-4.67%) ▼|PM210.36+1.86 (+0.89%) ▲|QCOM167.72-17.69 (-9.54%) ▼|RTX200.05+0.65 (+0.33%) ▲|SBUX103.34-2.17 (-2.06%) ▼|SCHW88.66-0.82 (-0.91%) ▼|SO94.04+1.05 (+1.12%) ▲|SPG216.89+1.17 (+0.54%) ▲|T21.46+0.54 (+2.56%) ▲|TMO703.64-5.54 (-0.78%) ▼|TMUS155.31+8.02 (+5.45%) ▲|TSLA396.93-6.37 (-1.58%) ▼|TXN302.07-9.35 (-3.00%) ▼|UBER65.09-0.65 (-0.99%) ▼|UNH408.45-2.46 (-0.60%) ▼|UNP302.17+0.24 (+0.08%) ▲|UPS108.29+0.96 (+0.90%) ▲|USB59.98-0.66 (-1.09%) ▼|V413.10+2.56 (+0.62%) ▲|VZ44.83+1.17 (+2.67%) ▲|WFC83.93-0.89 (-1.04%) ▼|WMT123.13+1.88 (+1.55%) ▲|XOM187.59+4.30 (+2.35%) ▲|
15.1 C
New York
Friday, October 30, 2026

Tag: Regulatory

newsFORsourcecompanycontentinformationreleases1market

Netcapital Announces Full Year Fiscal 2025 Financial Results – Updated

BOSTON, MA, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Netcapital Inc. (Nasdaq: NCPL, NCPLW) (the “Company”), a digital private capital markets ecosystem, today announced financial results for the full fiscal year 2025 ended April 30, 2025.

Prairie Provident Announces Second Quarter 2025 Results

CALGARY, Alberta, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Prairie Provident Resources Inc. ("Prairie Provident" or the "Company") (TSX:PPR) announces its financial and operating results for the second quarter of 2025. The Company’s interim financial statements for the three and six months ended June 30, 2025 and related Management’s Discussion and Analysis (“MD&A”) are available on our website at www.ppr.ca and filed on SEDAR+ at www.sedarplus.ca.

Global Digital Health Market Poised for Robust Growth at a CAGR of ~18% by 2032 Amid Rising Demand for Remote Care| DelveInsight

The digital health market is experiencing robust growth, driven by increasing adoption of telemedicine, wearable devices, and AI-powered health solutions. Rising healthcare costs and...

Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsight

Over the last ten years, cell-based immunotherapy has emerged as a promising approach for treating solid tumors. Several companies, including Iovance Biotherapeutics, Obsidian Therapeutics,...

Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsight

Over the last ten years, cell-based immunotherapy has emerged as a promising approach for treating solid tumors. Several companies, including Iovance Biotherapeutics, Obsidian Therapeutics,...

Peyto Reports Second Quarter 2025 Results

CALGARY, Alberta, Aug. 12, 2025 (GLOBE NEWSWIRE) --  Peyto Exploration & Development Corp. (TSX: PEY) ("Peyto" or the "Company") is pleased to report operating and financial results for the second quarter of 2025.

FurZapper Gains Attention in 2025 as Reusable Pet Hair Removal Solution for Laundry

Eco-friendly, chemical-free design appeals to pet owners seeking sustainable ways to manage fur in washing machines and dryers. 
Eco-friendly, chemical-free design appeals to pet owners seeking sustainable ways to manage fur in washing machines and dryers.

MEREN ANNOUNCES SECOND QUARTER 2025 RESULTS AND DECLARES THIRD QUARTERLY DIVIDEND

VANCOUVER, BC, Aug. 12, 2025 /CNW/ - (TSX: MER) (Nasdaq-Stockholm: MER) – Meren Energy Inc. ("Meren" or the "Company") today published its financial and operating...

Eupraxia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update

VICTORIA, British Columbia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, today announced its financial results for the second quarter of 2025 and provided a business update. All dollar values are in U.S. dollars unless stated otherwise.

Armata Pharmaceuticals Announces Second Quarter 2025 Results and Provides Corporate Update

Entered into secured credit agreement with Innoviva for $15 million maturing in 2029 Announced positive topline results from the Phase 1b/2a diSArm trial for AP-SA02 LOS...

Theravance Biopharma, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update

YUPELRI® (revefenacin) net sales of $66.3 million, recognized by Viatris, increased 22% year-over-year1Pivotal Phase 3 CYPRESS study enrollment on track to complete by late...

Caris Life Sciences Reports Second Quarter 2025 Financial Results

IRVING, Texas, Aug. 12, 2025 /PRNewswire/ -- Caris Life Sciences, Inc. (Nasdaq: CAI), a leading, patient-centric, next-generation AI TechBio company, today reported financial results...

FGLFIN Investments Named to Global Top 10 Investment Firms List for 2025 Following Strong Q3 Performance

Zurich, Switzerland, Aug. 12, 2025 (GLOBE NEWSWIRE) -- FGLFIN Investments, a leader in cryptocurrency trading and asset management, has been named to the Global Top 10 Investment Firms list for 2025. The recognition follows a strong third quarter in which the company delivered exceptional results across client portfolios, increased assets under management, and expanded its global market presence.

Terrestrial Energy Selected for DOE Office of Nuclear Energy Advanced Reactor Pilot Program for Accelerated Development

Advanced Reactor Pilot Program launched by DOE to expedite authorization and commercialization of advanced nuclear reactor designs

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRegulatory

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers